bf/NASDAQ:URGN_icon.jpeg

COM:UROGEN

UroGen Pharma

  • Stock

Last Close

11.55

22/11 21:00

Market Cap

502.60M

Beta: -

Volume Today

390.58K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.76
-
0.11
85.80%
0.01
89.91%
0.00
99.18%
0.10
108,637.62%
0.40
314.85%
0.47
17.74%
0.46
1.80%
cash conversion cycle
-23.14K
-
-2.50K
89.21%
-1.73K
30.76%
-254.80
-
21.50
108.44%
14.73
31.48%
35.36
140.02%
cash per share
1.50
-
1.78
18.84%
7.51
321.06%
6.43
14.40%
7.16
11.40%
7.03
1.91%
3.99
43.24%
4.38
9.89%
4.78
9.02%
company equity multiplier
1.19
-
1.41
18.72%
1.10
22.01%
1.15
4.24%
1.12
2.35%
1.27
12.80%
14.23
1,024.10%
-1.54
110.79%
-2.73
78.10%
days of inventory outstanding
1.37K
-
192.23
85.96%
710.47
-
342.00
51.86%
206.25
39.69%
221.20
7.25%
days of payables outstanding
24.51K
-
2.70K
88.99%
1.73K
35.92%
1.18K
-
409.52
65.39%
263.57
35.64%
253.99
3.63%
days of sales outstanding
1.73
-
8.86
412.61%
218.00
-
89.02
59.16%
72.05
19.06%
68.15
5.42%
dividend yield
ebit per revenue
0.05
-
-2.45
5,472.03%
-68.42
2,697.93%
-6.08K
8,789.12%
-10.74
99.82%
-1.92
82.12%
-1.23
36.07%
-0.79
35.49%
ebt per ebit
1.02
-
-2.43
337.88%
1.00
141.18%
0.98
2.29%
0.96
1.86%
0.99
2.78%
1.19
20.05%
1.37
15.33%
1.50
9.77%
effective tax rate
-0.00
-
-0.00
74.04%
0.04
2,752.74%
-0.03
161.43%
-0.01
50.87%
-0.01
20.70%
-0.04
279.46%
enterprise value multiple
-12.15
-
144.43
1,288.75%
-16.97
111.75%
-7.48
55.93%
-5.90
21.11%
-2.29
61.20%
-2.25
1.80%
-3.15
40.28%
-6.84
117.10%
fixed asset turnover
23.66
-
10.13
57.16%
1.19
88.26%
0.00
99.68%
2.81
73,370.88%
15.27
443.93%
17.17
12.45%
35.05
104.17%
free cash flow per share
-0.62
-
0.29
146.74%
-1.01
447.08%
-2.41
137.47%
-3.48
44.48%
-4.92
41.49%
-3.83
22.06%
-3.85
0.47%
-2.66
31.03%
gross profit margin
1.00
-
0.93
7.21%
-0.60
164.59%
1
267.11%
0.91
8.55%
0.89
2.39%
0.88
1.30%
0.89
0.65%
interest coverage
25.27
-
-9.37
-
-1.81
80.71%
inventory turnover
0.27
-
1.90
612.03%
0.51
-
1.07
107.74%
1.77
65.82%
1.65
6.76%
long term debt to capitalization
0.01
-
0.02
7.46%
0.05
195.26%
9.55
21,036.62%
2.96
69.04%
net income per ebt
1
-
1
0%
1.00
0.10%
1.00
0.07%
0.96
4.55%
1.03
7.41%
1.01
1.34%
1.01
0.27%
1.04
2.91%
net profit margin
-0.11
-
-2.45
2,114.13%
-67.07
2,635.86%
-5.58K
8,226.90%
-10.89
99.81%
-2.31
78.82%
-1.70
26.47%
-1.24
27.12%
operating cash flow per share
-0.60
-
0.35
158.38%
-0.98
381.52%
-2.37
140.59%
-3.46
45.98%
-4.86
40.53%
-3.80
21.86%
-3.84
1.06%
-2.65
31.01%
operating cycle
1.37K
-
201.09
85.33%
928.46
-
431.02
53.58%
278.30
35.43%
289.35
3.97%
operating profit margin
0.05
-
-2.45
5,472.03%
-68.42
2,697.93%
-6.08K
8,789.12%
-10.74
99.82%
-1.92
82.12%
-1.23
36.07%
-0.79
35.49%
payables turnover
0.01
-
0.14
808.36%
0.21
56.06%
0.31
-
0.89
188.94%
1.38
55.37%
1.44
3.77%
pretax profit margin
-0.11
-
-2.45
2,112.02%
-66.96
2,633.94%
-5.84K
8,623.65%
-10.60
99.82%
-2.28
78.53%
-1.68
26.27%
-1.19
29.18%
price fair value
10.28
-
10.26
0.16%
5.48
46.61%
7.53
37.40%
3.80
49.54%
4.07
7.21%
25.26
520.16%
-2.28
109.02%
-6.63
190.94%
receivables turnover
211.20
-
41.20
80.49%
1.67
-
4.10
144.89%
5.07
23.55%
5.36
5.73%
return on assets
-0.65
-
-0.08
87.14%
-0.26
214.45%
-0.73
175.97%
-0.50
32.01%
-1.05
112.01%
-0.93
12.12%
-0.80
13.42%
-0.57
28.44%
return on capital employed
-0.72
-
0.04
105.54%
-0.29
826.81%
-0.86
194.21%
-0.60
30.13%
-1.26
110.55%
-0.95
24.78%
-0.70
25.76%
-0.45
36.69%
return on equity
-0.78
-
-0.12
84.73%
-0.29
145.24%
-0.84
187.68%
-0.56
33.60%
-1.33
139.16%
-13.17
887.85%
1.23
109.34%
1.57
27.46%
total debt to capitalization
0.01
-
0.02
7.46%
0.05
195.26%
9.55
21,036.62%
2.91
69.53%

All numbers in (except ratios and percentages)